01:51 PM EDT, 03/26/2026 (MT Newswires) -- Kodiak Sciences ( KOD ) shares soared past 76% amid heavy trading after the firm said Thursday topline phase 3 results of tarcocimab tedromer showed superiority over sham in diabetic retinopathy patients, meeting its primary endpoint.

More than 10.5 million shares of the company traded intraday compared with a daily average of about 744,000.

Noodles (NDLS) reported a narrower Q4 adjusted loss and higher revenue from a year ago late Wednesday.

Shares surged more than 62% as intraday trading volume soared to over 1.4 million from a daily average of roughly 49,000.

Brown-Forman (BF.A, BF.B) is said to be a potential acquisition target of Pernod Ricard, which has held some initial talks with the maker of Jack Daniel's whiskey, Bloomberg reported Thursday, citing people familiar with the matter.

Shares of Brown-Forman jumped almost 12% as intraday trading volume climbed to more than 822,000 from a daily average of about 215,000.

Price: 40.08, Change: +17.33, Percent Change: +76.18